PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-310

  1. 8,396 Posts.
    lightbulb Created with Sketch. 257
    Thanks Torpy...great interview

    ...i feel that Scott performed very well and is a great advocate for PAR...given he manages a long/short fund it is encouraging that no shares have been sold and seem to have been thrown in the bottom draw and locked for good reason...i found his comment in relation to the company transitioning from a retail to larger fund shareholder base an interesting one

    ..the challenge for many here will be when to sell, if indeed they do...the insto's won't get any of my shares unless i have no option but to sell, something i have had to do in the past
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $82.20M
Open High Low Value Volume
23.5¢ 24.0¢ 22.5¢ $186.1K 801.8K

Buyers (Bids)

No. Vol. Price($)
4 33599 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 65498 1
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.